Talazoparib (Tala) in patients (pts) with colorectal cancer (CRC) with BRCA1/2 mutations (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
| Autor: | Yost, Kathleen J, Rothe, Michael, Mangat, Pam K., Garrett-Mayer, Elizabeth, Duvivier, Herbert Leon, Ahn, Eugene R., Cannon, Timothy Lewis, Chiu, Vi Kien, Khalil, Maged F., Kim, Brian, Prinz, Allison Marie, Grantham, Gina N., Gregory, Abby, Hinshaw, Dominique C., Halabi, Susan, Schilsky, Richard L. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p106-106, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|